Integral Ad Science
IAS was delisted on the 22nd of December, 2025.
165 hedge funds and large institutions have $1.64B invested in Integral Ad Science in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 53 increasing their positions, 57 reducing their positions, and 42 closing their positions.
391% more call options, than puts
Call options by funds: $231K | Put options by funds: $47K
0.27% more ownership
Funds ownership: 96.27% → 96.53% (+0.27%)
2% less capital invested
Capital invested by funds: $1.68B → $1.64B (-$39.9M)
7% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 57
10% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 42
4% less funds holding
Funds holding: 172 → 165 (-7)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$43.6M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$21.6M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.36M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$4.4M |
| 5 |
CC
Clearline Capital
New York
|
+$4.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCP
P2 Capital Partners
New York
|
-$27.9M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$8.47M |
| 3 |
CCM
Crestwood Capital Management
New York
|
-$7.03M |
| 4 |
JP Morgan Chase
New York
|
-$4.95M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$4.13M |
IAS Hedge Fund Activity: Q4 2024 in Review
165 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Integral Ad Science (IAS) for Q4 2024, worth a combined $1.64B — down 2.4% from $1.68B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of IAS and 38 opened new positions — a net loss of 4 holders — while 57 trimmed existing stakes and 53 added.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $43.6M. The largest seller was P2 Capital Partners, cutting an estimated $27.9M.
- 165 institutional investors held Integral Ad Science (IAS) as of Q4 2024, down from 172 in Q3 2024.
- Funds reported $1.64B of Integral Ad Science stock for Q4 2024, down 2.4% quarter-over-quarter.
- 38 funds opened new Integral Ad Science positions in Q4 2024 and 42 closed out, a net change of -4 holders.
- The largest Integral Ad Science buyer in Q4 2024 was Alyeska Investment Group, an estimated $43.6M added.
- The largest Integral Ad Science seller in Q4 2024 was P2 Capital Partners, an estimated $27.9M sold.
Based on aggregated 13F filings for Q4 2024.